Evolution of the Serbian pharmaceutical market alongside socioeconomic transition-Reference-Cited by-同舟云学术

Evolution of the Serbian pharmaceutical market alongside socioeconomic transition

Published:2015-01-16 Issue:3 Volume:15 Page:521-530
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Jakovljevic Mihajlo B¹,Djordjevic Natasa¹,Jurisevic Milena²,Jankovic Slobodan¹³

Affiliation:

1. 1Head of Graduate Health Economics & Pharmacoeconomics Curricula, Department of Pharmacology and Toxicology, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovica 69, 34000 Kragujevac, Serbia

2. 2Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia

3. 3Clinical Pharmacology Department, Clinical Center Kragujevac, Kragujevac, Serbia

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1586/14737167.2015.1003044

Reference44 articles.

1. European Healthcare Policies for Controlling Drug Expenditure

2. European drug shortages: a call for action!

3. Financial crisis, austerity, and health in Europe

4. The Transition of Young People in a Transitional Society: The Case of Serbia

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Europeanization of health policy in post-communist European societies: Comparison of six Western Balkan countries;Health Policy;2022-08

2. A Global Assessment of Sustainable Development: Integrating Socioeconomic, Resource and Environmental Dimensions;Frontiers in Energy Research;2022-02-14

3. Implementation of the Nationwide Electronic Health Record System in Serbia: Challenges, Lessons Learned, and Early Outcomes;Acta clinica croatica;2022

4. Pricing and Reimbursement of Patent-Protected Medicines: Challenges and Lessons from South-Eastern Europe;Applied Health Economics and Health Policy;2021-09-23

5. Clinical and economic impact of medication reconciliation by designated ward pharmacists in a hospitalist-managed acute medical unit;Research in Social and Administrative Pharmacy;2021-06